SAS

Knowing that a physician has been a high prescriber in the past is no longer enough information to set you apart from the competition. Using advanced analytics in-house can help you predict outcomes of promotions and lead to more focused marketing ? without having to rely on outside consultants. The paper includes case studies of several companies, including one that boosted earnings by $27 million over four months and another that saw a 19 percent gain in prescribing.

This white paper shows how to develop, execute and manage the transformation, analysis and submission of clinical research data with SAS® Drug Development. It includes an executive summary that outlines current industry challenges. And, it answers the top ten questions life sciences executives confront when trying to balance innovation with regulatory compliance.

This white paper shows how to develop, execute and manage the transformation, analysis and submission of clinical research data with SAS® Drug Development. It includes an executive summary that outlines current industry challenges. And, it answers the top ten questions life sciences executives confront when trying to balance innovation with regulatory compliance.

Information technology is finally up to the task of cost-effective clinical research. But there are still some significant barriers to gaining all the benefits of the technology, in particular, interoperability. This white paper explores the need for a consistent industry architecture that allows life sciences firms to connect their enterprises and benefit from unified data integration, process consistency and rapid communication of meaningful drug findings.